Immunoinflammatory and oxidative alterations in subjects with schizophrenia under clozapine: A meta-analysis-Reference-Cited by-同舟云学术

Immunoinflammatory and oxidative alterations in subjects with schizophrenia under clozapine: A meta-analysis

Published:2023-08 Issue: Volume:73 Page:82-95
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Martins Paulo Levi Bezerra,Moura Ian Araújo^ORCID,Mendes Gabrielle,Ribeiro Vitória Cristina Almeida Flexa,Arnaud André,Gama Clarissa S.,Maes Michael,Macedo Danielle S.^ORCID,Pinto Joel Porfirio

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology

Reference52 articles.

1. Serum TNF-α, IL-10 and IL-2 in schizophrenic patients before and after treatment with risperidone and clozapine;Ajami;Iran. J. Immunol.,2014

2. Evidence-based guidelines for the pharmacological treatment of schizophrenia: updated recommendations from the British Association for Psychopharmacology;Barnes;J. Psychopharmacol.,2020

3. Obstetric conditions and risk of first admission with schizophrenia: a Danish national register based study;Byrne;Schizophr. Res.,2007

4. Prevalence and medical costs of chronic diseases among adult medicaid beneficiaries;Chapel;Am. J. Prev. Med.,2017

5. The Economic Burden of Schizophrenia in the United States in 2013;Cloutier;J. Clin. Psychiatry,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting antipsychotic responsiveness using a machine learning classifier trained on plasma levels of inflammatory markers in schizophrenia;2024-08-10

2. Large-Scale Mendelian Randomization Study Reveals Circulating Blood-based Proteomic Biomarkers for Psychopathology and Cognitive Task Performance;2024-01-20

3. Correlation of Immune-Inflammatory Response System (IRS)/Compensatory Immune-Regulatory Reflex System (CIRS) with White Matter Integrity in First-Episode Patients with Schizophrenia;Molecular Neurobiology;2023-11-07

4. Low-dose lithium adjunct to atypical antipsychotic treatment nearly improved cognitive impairment, deteriorated the gray-matter volume, and decreased the interleukin-6 level in drug-naive patients with first schizophrenia symptoms: a follow-up pilot study;Schizophrenia;2023-10-14

5. Immunological Biomarkers as Predictors of Treatment Response in Psychotic Disorders;Journal of Personalized Medicine;2023-09-15